查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1338939

肌腱炎治療市場、份額、市場規模、趨勢、行業分析報告：按治療、按症狀、按地區、按細分市場、預測，2023-2032 年

Tendonitis Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment (Therapy and Surgery); By Condition; By Region; Segment Forecast, 2023-2032
出版日期: | 出版商: Polaris Market Research | 英文 114 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，全球肌腱炎治療市場規模預計將達到2,916.4億美元。 該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

多種類型的運動相關損傷的負擔日益加重，新產品和技術的不斷創新，縮短康復時間並提供更好治療設施的治療方法，以及世界各地政府組織不斷加大的努力。推動市場成長的關鍵因素。 此外，骨科手術的高普及率、已建立的醫療基礎設施和治療設施以及主要參與者實施產品組合擴張可能會以更快的速度刺激全球市場。 例如，2022年11月，Camber Pharmaceuticals增加了一款新產品 "□普生口服混懸液" 。 這種新開發的產品適用於治療肌腱炎症狀。

世界各地的患者越來越多地尋求更多的非侵入性治療，以最大限度地減少停機時間並加快康復速度，包括物理治療、超音波治療和衝擊波治療。推動了治療需求。 此外，肌腱置換和再生技術的不斷創新正在滿足對替代性人工組織快速增長的需求，對市場產生積極影響。 一種透過將患者的血小板注射到受影響的肌腱中刺激組織修復來促進癒合的新型治療方法越來越受歡迎，這種治療方法用於治療肘部、肩部和膝蓋的肌腱炎，在治療中已顯示出希望。癌症，並在世界各地獲得了極大的普及和關注。

除此之外，隨著醫療技術的快速進步，現在世界各地出現了不同類型的肌腱炎創新治療方法，包括藥物治療、物理治療和手術治療，使得治療效果和效率不斷提高。 儘管如此，早期診斷的重要性日益得到認可和廣泛傳播，為市場創造了巨大的成長機會。

肌腱炎治療市場報告亮點

治療產業在 2022 年佔據最大的市場份額，這主要是由於物理治療的採用，因為它能夠讓患者放心，並且作為一種具有成本效益的選擇而廣受歡迎。

由於人們生活方式和體育活動傾向的不斷變化，高爾夫球手的肘部部分預計在預測期內將以最高的複合年增長率增長。

由於人民消費能力不斷增強、基礎設施發達以及與醫療技術公司合作的滲透率較高，北美地區在2022年將佔據全球市場的最大份額。

全球主要市場參與者包括 Almatica Pharma、Teva Pharmaceuticals Industries、Abbott Laboratories、Stryker Corporation、Ingelheim Pharmaceuticals 和 Zimmer Biomet Holdings。

目錄

第1章簡介

第 2 章執行摘要

第3章研究方法

第4章全球肌腱炎治療市場洞察

  • 肌腱炎治療市場 - 產業概況
  • 肌腱炎治療市場動態
    • 推動者和機會
      • 運動傷害增加
      • 提高對肌腱炎治療方案的認識
    • 抑制因素和挑戰
      • 新興國家的保險覆蓋範圍有限
  • 杵分析
  • 肌腱炎治療產業的趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第5章全球肌腱炎治療市場（依治療）

  • 主要發現
  • 簡介
  • 治療
  • 手術

第 6 章全球肌腱炎治療市場（依症狀）

  • 主要發現
  • 簡介
  • 網球肘
  • 高爾夫球肘
  • 投手肘
  • 跳線膝蓋
  • 游泳者的肩膀
  • 跟腱炎

第 7 章全球肌腱炎治療市場（按地區）

  • 主要發現
  • 簡介
    • 2019-2032 年肌腱炎治療市場評估（按地區）
  • 肌腱炎治療市場 - 北美
    • 北美：肌腱炎治療市場，依症狀，2019-2032 年
    • 北美：肌腱炎治療市場（依治療方式），2019-2032 年
    • 肌腱炎治療市場 - 美國
    • 肌腱炎治療市場 - 加拿大
  • 肌腱炎治療市場 - 歐洲
    • 歐洲：肌腱炎治療市場，依情況劃分，2019-2032 年
    • 歐洲：肌腱炎治療市場（依治療方式），2019-2032 年
    • 肌腱炎治療市場 - 英國
    • 肌腱炎治療市場 - 法國
    • 肌腱炎治療市場 - 德國
    • 肌腱炎治療市場 - 義大利
    • 肌腱炎治療市場 - 西班牙
    • 肌腱炎治療市場 - 荷蘭
    • 肌腱炎治療市場 - 俄羅斯
  • 肌腱炎治療市場 - 亞太地區
    • 亞太地區：肌腱炎治療市場，依症狀，2019-2032 年
    • 亞太地區：肌腱炎治療市場（依治療方式），2019-2032 年
    • 肌腱炎治療市場 - 中國
    • 肌腱炎治療市場 - 印度
    • 肌腱炎治療市場 - 馬來西亞
    • 肌腱炎治療市場 - 日本
    • 肌腱炎治療市場—印度尼西亞
    • 肌腱炎治療市場 - 韓國
  • 肌腱炎治療市場 - 中東和非洲
    • 中東和非洲：肌腱炎治療市場（按症狀），2019-2032 年
    • 中東與非洲：肌腱炎治療市場（依治療方式），2019-2032 年
    • 肌腱炎治療市場 - 沙烏地阿拉伯
    • 肌腱炎治療市場 - 阿拉伯聯合大公國
    • 肌腱炎治療市場 - 以色列
    • 肌腱炎治療市場 - 南非
  • 肌腱炎治療市場 - 拉丁美洲
    • 拉丁美洲：肌腱炎治療市場（按症狀），2019-2032 年
    • 拉丁美洲：肌腱炎治療市場（依治療方式），2019-2032 年
    • 肌腱炎治療市場 - 墨西哥
    • 肌腱炎治療市場 - 巴西
    • 肌腱炎治療市場 - 阿根廷

第8章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第9章公司簡介

  • Teva Pharmaceuticals
  • Almatica Pharma
  • Abbott
  • Boehringer Ingelheim
  • Bayer
  • Merck
  • Pfizer
  • Teikoku Pharma
  • Stryker Corporation
  • 3M Company
  • Zimmer Biomet
  • AKSIGEN
  • DJO Global
  • AstraZeneca
  • GlaxoSmithKline
  • Camber Pharmaceuticals
  • CoNextions Inc
Product Code: PM3383

The global tendonitis treatment market size is expected to reach USD 291.64 billion by 2032, according to a new study by Polaris Market Research. The report "Tendonitis Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment (Therapy and Surgery); By Condition; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising burden of several types of sports-related injuries, constant innovations of new products and technologies, and treatment modalities to offer better treatment facilities with less recovery time, along with the growing efforts undertaken by government organizations worldwide, are among the leading factors driving the market growth. Moreover, the high prevalence of orthopedic procedures, and presence of well-established healthcare infrastructure and treatment facilities, and the implementation of product portfolio expansion by major players, will further stimulate the global market at a significant pace. For instance, in November 2022, Camber Pharmaceuticals added a new product, "Naproxen Oral Suspension." The newly developed product is being indicated to treat the symptoms of tendonitis.

Patients across the globe are increasingly seeking more non-invasive treatment options that offer minimal downtime and faster recovery times, which fuels the demand for therapies such as physical therapy, ultrasound therapy, and shockwave therapy. Additionally, the continuous innovations in tendon replacement and regeneration techniques address the surging demand for alternative engineered tissue and positively influence the market. There has been a significant rise in the penetration for a new kind of treatment, which involves injecting a patient's platelets into the affected tendon to promote healing that can stimulate tissue repair, and the therapy has shown promise in treating tendonitis in the elbow, shoulder, and knee, which is gaining huge popularity and traction all over the world.

Apart from this, with the rapid advances in medical technology, various types of innovative treatment options are available worldwide for tendonitis, including medications, physical therapy, and surgery, which led to increased effectiveness and efficiency of treatment. Despite this, there is an emerging prevalence and awareness regarding the importance of early diagnosis, which creates huge growth opportunities for the market.

Tendonitis Treatment Market Report Highlights

Therapy segment accounted for largest market share in 2022, which is mainly driven by adoption of physical therapy due to its ability to relive patients and its popularity as a cost-efficient option

Golfer's elbow segment is expected to grow at a highest CAGR during the anticipated period, on account of constant changes in people lifestyles and inclination towards sports activity

North America region dominated the global market with maximum share in 2022, owing to increase in people spending capacity, presence of well-developed infrastructure, and high penetration to collaborate with med-tech companies

The global key market players Almatica Pharma, Teva Pharmaceuticals Industries, Abbott Laboratories, Stryker Corporation, Ingelheim Pharmaceuticals, and Zimmer Biomet Holdings

Polaris Market Research has segmented the tendonitis treatment market report based on treatment, condition, and region:

Tendonitis Treatment, Treatment Outlook (Revenue - USD Billion, 2019 - 2032)

  • Therapy
  • Surgery

Tendonitis Treatment, Condition Outlook (Revenue - USD Billion, 2019 - 2032)

  • Tennis Elbow
  • Golfer's Elbow
  • Pitcher's Elbow
  • Jumper's Knee
  • Swimmer's Shoulder
  • Achille Tendonitis

Tendonitis Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Tendonitis Treatment Market Insights

  • 4.1. Tendonitis Treatment Market - Industry Snapshot
  • 4.2. Tendonitis Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of sports injuries
      • 4.2.1.2. Growing awareness of tendonitis treatment options
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Insurance coverage is limited in emerging countries
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Tendonitis Treatment Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Tendonitis Treatment Market, by Treatment

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Tendonitis Treatment, by Treatment, 2019-2032 (USD Billion)
  • 5.3. Therapy
    • 5.3.1. Global Tendonitis Treatment Market, by Therapy, by Region, 2019-2032 (USD Billion)
  • 5.4. Surgery
    • 5.4.1. Global Tendonitis Treatment Market, by Surgery, by Region, 2019-2032 (USD Billion)

6. Global Tendonitis Treatment Market, by Condition

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • 6.3. Tennis Elbow
    • 6.3.1. Global Tendonitis Treatment Market, by Tennis Elbow, by Region, 2019-2032 (USD Billion)
  • 6.4. Golfer's Elbow
    • 6.4.1. Global Tendonitis Treatment Market, by Golfer's Elbow, by Region, 2019-2032 (USD Billion)
  • 6.5. Pitcher's Elbow
    • 6.5.1. Global Tendonitis Treatment Market, by Pitcher's Elbow, by Region, 2019-2032 (USD Billion)
  • 6.6. Jumper's Knee
    • 6.6.1. Global Tendonitis Treatment Market, by Jumper's Knee, by Region, 2019-2032 (USD Billion)
  • 6.7. Swimmer's Shoulder
    • 6.7.1. Global Tendonitis Treatment Market, by Swimmer's Shoulder, by Region, 2019-2032 (USD Billion)
  • 6.8. Achilles Tendonitis
    • 6.8.1. Global Tendonitis Treatment Market, by Achilles Tendonitis, by Region, 2019-2032 (USD Billion)

7. Global Tendonitis Treatment Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Tendonitis Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Tendonitis Treatment Market - North America
    • 7.3.1. North America: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
    • 7.3.2. North America: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.3.3. Tendonitis Treatment Market - U.S.
      • 7.3.3.1. U.S.: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.3.4. Tendonitis Treatment Market - Canada
      • 7.3.4.1. Canada: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • 7.4. Tendonitis Treatment Market - Europe
    • 7.4.1. Europe: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.4.3. Tendonitis Treatment Market - UK
      • 7.4.3.1. UK: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.4.4. Tendonitis Treatment Market - France
      • 7.4.4.1. France: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.4.5. Tendonitis Treatment Market - Germany
      • 7.4.5.1. Germany: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.4.6. Tendonitis Treatment Market - Italy
      • 7.4.6.1. Italy: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.4.7. Tendonitis Treatment Market - Spain
      • 7.4.7.1. Spain: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.4.8. Tendonitis Treatment Market - Netherlands
      • 7.4.8.1. Netherlands: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.4.9. Tendonitis Treatment Market - Russia
      • 7.4.9.1. Russia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • 7.5. Tendonitis Treatment Market - Asia Pacific
    • 7.5.1. Asia Pacific: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.5.3. Tendonitis Treatment Market - China
      • 7.5.3.1. China: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.5.4. Tendonitis Treatment Market - India
      • 7.5.4.1. India: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.5.5. Tendonitis Treatment Market - Malaysia
      • 7.5.5.1. Malaysia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.5.6. Tendonitis Treatment Market - Japan
      • 7.5.6.1. Japan: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.5.7. Tendonitis Treatment Market - Indonesia
      • 7.5.7.1. Indonesia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.5.8. Tendonitis Treatment Market - South Korea
      • 7.5.8.1. South Korea: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • 7.6. Tendonitis Treatment Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.6.3. Tendonitis Treatment Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.6.4. Tendonitis Treatment Market - UAE
      • 7.6.4.1. UAE: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.6.5. Tendonitis Treatment Market - Israel
      • 7.6.5.1. Israel: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.6.6. Tendonitis Treatment Market - South Africa
      • 7.6.6.1. South Africa: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • 7.7. Tendonitis Treatment Market - Latin America
    • 7.7.1. Latin America: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.7.3. Tendonitis Treatment Market - Mexico
      • 7.7.3.1. Mexico: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.7.4. Tendonitis Treatment Market - Brazil
      • 7.7.4.1. Brazil: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.7.5. Tendonitis Treatment Market - Argentina
      • 7.7.5.1. Argentina: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Teva Pharmaceuticals
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Almatica Pharma
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Abbott
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Boehringer Ingelheim
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Bayer
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Merck
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Pfizer
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Teikoku Pharma
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Stryker Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. 3M Company
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Zimmer Biomet
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. AKSIGEN
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. DJO Global
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. AstraZeneca
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development
  • 9.15. GlaxoSmithKline
    • 9.15.1. Company Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Development
  • 9.16. Camber Pharmaceuticals
    • 9.16.1. Company Overview
    • 9.16.2. Financial Performance
    • 9.16.3. Product Benchmarking
    • 9.16.4. Recent Development
  • 9.17. CoNextions Inc
    • 9.17.1. Company Overview
    • 9.17.2. Financial Performance
    • 9.17.3. Product Benchmarking
    • 9.17.4. Recent Development

List of Tables

  • Table 1 Global Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 2 Global Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 3 Tendonitis Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 5 North America: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 6 U.S.: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 7 U.S.: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 8 Canada: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 9 Canada: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 10 Europe: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 11 Europe: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 12 UK: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 13 UK: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 14 France: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 15 France: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 16 Germany: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 17 Germany: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 18 Italy: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 19 Italy: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 20 Spain: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 21 Spain: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 24 Russia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 25 Russia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 28 China: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 29 China: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 30 India: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 31 India: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 34 Japan: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 35 Japan: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 38 South Korea: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 39 South Korea: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 44 UAE: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 45 UAE: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 46 Israel: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 47 Israel: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 48 South Africa: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 49 South Africa: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 50 Latin America: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 51 Latin America: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 52 Mexico: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 53 Mexico: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 54 Brazil: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 55 Brazil: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 56 Argentina: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 57 Argentina: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Tendonitis Treatment Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Condition
  • Figure 7 Global Tendonitis Treatment Market, by Condition, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Treatment
  • Figure 9 Global Tendonitis Treatment Market, by Treatment, 2022 & 2032 (USD Billion)
  • Figure 10 Tendonitis Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Tendonitis Treatment Market